Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma

Published:2004-08-02 Issue:6 Volume:34 Page:485-490
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Kumar S,Lacy M Q,Dispenzieri A,Rajkumar S V,Fonseca R,Geyer S,Allmer C,Witzig T E,Lust J A,Greipp P R,Kyle R A,Litzow M R,Gertz M A

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704633.pdf

Reference36 articles.

1. Jemal A, Murray T, Samuels A et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5–26.

2. Kyle RA . Long-term survival in multiple myeloma. N Engl J Med 1983; 308: 314–316.

3. Bataille R, Harousseau JL . Multiple myeloma. N Engl J Med 1997; 336: 1657–1664.

4. Alexanian R, Bonnet J, Gehan E et al. Combination chemotherapy for multiple myeloma. Cancer 1972; 30: 382–389.

5. McElwain TJ, Powles RL . High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet 1983; 2: 822–824.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma;Drug Delivery and Translational Research;2023-01-02

2. DEXAMETHASONE MONOTHERAPY IN A FRAIL AND CHEMOTHERAPY-INELIGIBLE PATIENT WITH END-STAGE MULTIPLE MYELOMA: A CASE REPORT AND LITERATURE REVIEW;WORLD CANCER RES J;2022

3. The evolving role and utility of off-label drug use in multiple myeloma;Exploration of Targeted Anti-tumor Therapy;2021-08-23

4. The Role of Targeted Therapy in Multiple Myeloma;Resistance to Targeted Anti-Cancer Therapeutics;2021

5. BEAM-Modified Conditioning Therapy with Cisplatin+Dexamethasone Instead of Carmustine Prior to Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma;Annals of Transplantation;2019-10-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3